“Neutralizing Interleukin-13 with Tralokinumab Reduces Abundance of S. aureus in Adolescents with Atopic Dermatitis” (2024) SKIN The Journal of Cutaneous Medicine, 8(1), p. s324. doi:10.25251/skin.8.supp.324.